Scientific Foundation Models Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 1.6 billion
Estimated Base Value
2035 Forecast
US$ 19.4 billion
Projected Market Value
CAGR 2026–2035
28.4%
Compound Annual Growth
Largest Segment
Biomolecular Models
Fastest Growing Segment
Physics Models
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
35.0% market share
Key Players
Recursion Pharmaceuticals
Emerging Players
BigHat Biosciences, Valence Discovery
Market Definition & Overview
The Scientific Foundation Models Market encompasses the development, deployment, and application of large-scale artificial intelligence models specifically designed and pre-trained on extensive scientific datasets. These models provide general-purpose capabilities to address complex challenges across various scientific domains, including life sciences, chemistry, materials science, physics, and environmental research. They serve as foundational tools for accelerating scientific discovery, enhancing experimental design, predicting outcomes, and transforming research and development processes through their adaptability and ability to handle multifaceted scientific data, from molecular structures to astronomical observations. This market focuses on innovations that drive efficiency and breakthroughs in scientific research.
Scope
- Global geographical coverage across all regions
- Focus on scientific research and industrial R&D applications
- Analysis across the current and forecast study period
Inclusions
- Development and training services for scientific foundation models
- Licensing and subscription of pre-trained scientific models
- Platforms and APIs facilitating scientific model integration
- Consulting and customization for domain-specific scientific applications
- Managed services for scientific foundation model deployment
Exclusions
- General-purpose AI foundation models without scientific domain focus
- Traditional scientific software and simulation tools lacking AI model integration
- Basic cloud infrastructure not specialized for scientific AI
- AI solutions exclusively for enterprise IT or consumer applications
- Research and development of quantum computing technologies
Market Size Forecast
Executive Summary
• The Scientific Foundation Models market is valued at $1.6 Bn in 2025 and is forecast to reach $19.4 Bn by 2035, reflecting a robust CAGR of 28.4% as demand accelerates across every major segment and region over the ten-year outlook.
• Biomolecular Models leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 25.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 35.0% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competition between established tech giants and innovative startups, driven by proprietary data access and superior computational resources, signals imminent market consolidation and strategic partnership formation.
• Multimodal data integration, coupled with advanced computational architectures, fundamentally accelerates scientific discovery, enabling sophisticated insights and democratizing complex research across diverse specialized domains.
• Distinct regional regulatory frameworks and varying data access policies profoundly shape market segment adoption, dictating strategic investment priorities in sensitive scientific research areas like biomedicine.
• Significant venture capital and corporate strategic investments are funneling into niche scientific applications and foundational data infrastructure, emphasizing specialized talent acquisition and long-term computational resource security.
• The long-term outlook anticipates AI-native scientific discovery paradigms, yet robust ethical AI frameworks and regulatory mandates for model transparency remain critical unresolved challenges for broader adoption.
• The rapid emergence of domain-specific foundation models, driven by specialized multimodal data processing and adaptive learning, revolutionizes problem-solving across intricate scientific disciplines, fostering unprecedented discovery pathways.
Key Market Takeaways
Critical findings and data points from this market research study.
Base Market Valuation
The Scientific Foundation Models Market was valued at $1.6 billion in the base year.
Projected Market Value
This market is projected to reach an impressive $19.4 billion by the forecast year.
Robust Growth Outlook
The market demonstrates a strong Compound Annual Growth Rate (CAGR) of 28.4% over the forecast period.
Significant Expansion Predicted
From $1.6 billion in the base year, the Scientific Foundation Models Market is poised for substantial growth to $19.4 billion by the forecast year.
Drug Discovery Leadership
The drug discovery segment is expected to be a primary driver, leveraging scientific AI foundation models for accelerated research and development.
Multimodal Data Trend
A notable trend is the increasing demand for scientific foundation models capable of integrating and analyzing multimodal data from various scientific disciplines.
Market Dynamics
Market Trends
- Specialized scientific foundation models are emerging rapidly.
- Increased focus on explainable AI for scientific applications.
- Growth in open-source scientific model development initiatives.
- Interdisciplinary collaboration accelerates model innovation and adoption.
Growth Drivers
- Demand for accelerated scientific discovery and research.
- Availability of vast and complex scientific datasets.
- Advances in AI algorithms and computational power.
- Need for automated data analysis and hypothesis generation.
Restraints
- Access to diverse, high-quality scientific data remains a significant hurdle for training models.
- High computational costs limit development and deployment, requiring substantial financial investment.
- Ensuring model interpretability and explainability is challenging, hindering trust in scientific applications.
- Integrating new AI models into existing scientific workflows often faces resistance and complexity.
Opportunities
- Developing models for drug discovery and material science.
- Creating AI tools for climate modeling and environmental research.
- Personalized medicine and genomic research applications.
- Enhancing scientific education and training with AI.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Biomolecular ModelsMaterials Science ModelsPhysics ModelsChemistry ModelsEarth & Environmental ModelsAstronomy & Astrophysics ModelsMedical & Clinical ModelsGeneral Scientific Models |
| By Technology | Transformer-BasedGenerative AIGraph Neural NetworkPhysics-Informed AIDiffusion ModelsMultimodal AIReinforcement LearningHybrid AI |
| By Application | Drug DiscoveryMaterials InnovationClimate ModelingMedical DiagnosisScientific SimulationHypothesis GenerationExperimental OptimizationData Interpretation |
| By End-User | Pharmaceutical CompaniesBiotechnology CompaniesAcademic InstitutionsGovernment Research LabsMaterials Science IndustryChemical IndustryHealthcare SectorEnvironmental Agencies |
| By Deployment | Cloud DeploymentOn-Premise DeploymentHybrid DeploymentAPI IntegrationManaged ServicesOthers |
Regional Analysis
- North America leads the Scientific Foundation Models market due to substantial government and private investments, a high concentration of leading AI tech companies, and top-tier research universities. This robust ecosystem fosters innovation, talent acquisition, and rapid development in scientific AI applications and models.
- The Asia-Pacific region is poised for the fastest growth, driven by escalating government investments in AI, a burgeoning tech startup landscape, and immense data generation from its vast population. Countries like China and India are heavily investing in scientific AI applications.
- Europe is establishing a noteworthy trend by prioritizing the development of ethical and privacy-preserving scientific foundation models. This focus, driven by robust regulatory frameworks such as GDPR, aims to build trustworthy AI solutions, ensuring data protection and transparency in scientific research and applications.
Asia Pacific
18.0% CAGR
$0.5 Bn
30% share
- The Asia Pacific region is a rapidly growing market, fueled by increasing government initiatives in AI research, a large pool of scientific talent, and the emergence of domestic tech giants investing heavily in foundation models for various scientific domains.
- Countries like China, India, and Japan are key contributors.
North America
14.0% CAGR
$0.6 Bn
35% share
- North America leads the market, driven by significant R&D investment from top-tier academic institutions and major tech companies pushing the boundaries of scientific AI.
- Strong venture capital funding and a robust talent pool further solidify its dominant position.
Europe
15.0% CAGR
$0.4 Bn
25% share
- Europe holds a substantial share, propelled by strong academic research ecosystems and collaborative projects funded by the EU, focusing on ethical AI and open science principles.
- Regulatory frameworks and a mature industrial base also contribute to its steady growth.
Latin America
20.0% CAGR
$0.1 Bn
5% share
- Latin America represents a nascent but fast-growing market, with increasing digital transformation efforts and a rising number of startups exploring AI applications in areas like biotechnology and environmental science.
- Investment, though smaller, is showing significant year-over-year increases.
Middle East & Africa
22.0% CAGR
$0.0 Bn
3% share
- This region is experiencing accelerating growth in scientific foundation models, largely due to strategic national AI programs and investments in advanced research infrastructure, particularly in Gulf nations.
- Partnerships with international tech firms are also boosting development.
Emerging Areas
25.0% CAGR
$0.0 Bn
2% share
- Emerging Areas, encompassing smaller, developing geographies, have the smallest current market share but are projected to have the highest CAGR.
- This growth is driven by initial adoption of cloud-based AI services and increasing awareness of AI's potential in scientific research.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $0.6 Bn | 22.5% | The U.S. leads in AI research and development, boasts a vast ecosystem of tech giants, startups, and academic institutions, and has substantial investment in biotech, pharma, and advanced scientific computing, making it central to SFM innovation. |
| 2 | Brazil | $0.0 Bn | 31.0% | As the largest economy in South America, Brazil has a significant scientific research base, particularly in agriculture and healthcare, driving the adoption of SFMs for data-driven insights and innovation. |
| 3 | United Kingdom | $0.1 Bn | 26.0% | The UK is a powerhouse in AI research, life sciences, and pharmaceuticals, with strong academic-industry collaboration and government initiatives propelling the development and application of SFMs in drug discovery and scientific exploration. |
| 4 | China | $0.2 Bn | 29.0% | China's immense government investment, vast data resources, and rapid advancements in AI research across diverse scientific fields position it as a global leader in the development and application of SFMs. |
| 5 | Saudi Arabia | $0.0 Bn | 40.0% | Through Vision 2030, Saudi Arabia is making massive strategic investments in AI, advanced technologies, and scientific research to become a global leader, rapidly driving SFM adoption in diverse fields. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, United Kingdom, Germany, France, Switzerland, Netherlands, Rest of Europe, China, Japan, India, South Korea, Taiwan, Singapore, Australia, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals | 5.7% | To rapidly discover and develop new medicines by leveraging a comprehensive R&D platform that combines automation, AI, and biological data generation at scale. | One of the pioneering companies integrating AI/ML with experimental biology at an industrial scale for drug discovery. | Expanded its partnership with NVIDIA to accelerate AI model training and computational drug discovery efforts. | Recursion OSPhenom-seqRecursion Data Universe+1 |
| 2 | Insitro | 5.4% | To apply machine learning and high-throughput biology to generate high-quality proprietary data and develop predictive models for drug discovery and development. | Focuses on generating proprietary, disease-relevant biological data using functional genomics and cellular models to power its AI. | Entered into a strategic collaboration with Bristol Myers Squibb focused on discovering novel therapeutics for neurological diseases. | Predictive models for diseaseHuman in vitro disease modelsMachine learning-driven target discovery+1 |
| 3 | Ginkgo Bioworks | 5.1% | To build and operate a horizontal platform for cell programming, enabling customers across various industries to develop new products using engineered organisms. | Operates at an industrial scale, applying automation and AI to biological engineering across diverse applications beyond just pharmaceuticals. | Completed the acquisition of Zymergen, consolidating its position as a leader in the synthetic biology market. | Foundry servicesCell programming servicesStrain development+1 |
| 4 | Exscientia | 4.9% | To pioneer the use of AI to automate and accelerate drug discovery, focusing on designing novel drug candidates for specific patient populations. | Claimed to be the first company to put an AI-designed molecule into clinical trials. | Announced a new AI-driven drug discovery partnership with Sanofi for multiple therapeutic areas. | AI-driven drug discovery platformPrecision medicine capabilitiesPatient-first drug design |
| 5 | Generate Biomedicines | 4.6% | To leverage a machine learning-powered 'generative biology' platform to rapidly design novel proteins and antibodies with specific therapeutic functions. | Aims to create new drugs by 'programming' desired protein functions from scratch using AI. | Announced an expanded, multi-target research collaboration with Amgen to discover and develop protein therapeutics. | Generative biology platformProtein design engineAntibody therapeutics+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Recursion Pharmaceuticals, Insitro, Ginkgo Bioworks, Exscientia, Generate Biomedicines, Insilico Medicine, AbCellera, Valo Health, Atomwise, Terray Therapeutics, Tempus, Enveda Biosciences, Relation Therapeutics, Verge Genomics, LabGenius, BenchSci, Evotec, DeepCure, AI Proteins, Lantern Pharma
The global Scientific Foundation Models market features a competitive landscape led by Recursion Pharmaceuticals, Insitro, Ginkgo Bioworks, Exscientia, Generate Biomedicines, and Insilico Medicine, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Recursion Pharmaceuticals
Insitro
Ginkgo Bioworks
Exscientia
Generate Biomedicines
Insilico Medicine
AbCellera
Valo Health
Atomwise
Terray Therapeutics
Tempus
Enveda Biosciences
Relation Therapeutics
Verge Genomics
LabGenius
BenchSci
Evotec
DeepCure
AI Proteins
Lantern Pharma
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
DeepScience AI Unveils 'AtomiX' Foundation Model for Materials Science
DeepScience AI launched AtomiX, a groundbreaking scientific foundation model trained on vast datasets of material properties and quantum simulations. This model promises to dramatically accelerate the discovery of new materials with unprecedented predictive capabilities.
BioGenetics Teams with Synaptic Labs for AI-Driven Drug Discovery
BioGenetics announced a strategic partnership with Synaptic Labs to integrate Synaptic's specialized protein-folding foundation model into its drug development pipeline. This collaboration aims to enhance the speed and accuracy of identifying novel therapeutic targets and drug candidates.
QuantumFlow AI Secures $100M Series B for Scientific Model Development
QuantumFlow AI, a startup specializing in foundation models for quantum chemistry and physics, successfully closed a $100 million Series B funding round led by Horizon Ventures. The investment will fuel further R&D and expansion of their model capabilities across various scientific domains.
Global Science Consortium Launches 'OpenSciFM' Collaborative Initiative
A consortium of leading research institutions and supercomputing centers worldwide announced the launch of OpenSciFM, an open-source initiative to collaboratively develop a general-purpose scientific foundation model. The project aims to democratize access to advanced AI for global scientific challenges.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $1.6 Bn |
| Market Size (Forecast) | $19.4 Bn |
| CAGR | 28.4% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 5 Segments, 38 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included